SHSAX vs. RYOIX
SHSAX (BlackRock Health Sciences Opportunities Portfolio) and RYOIX (Rydex Biotechnology Fund) are both Health & Biotech Equities funds. Over the past 10 years, SHSAX returned 10.05%/yr vs 10.54%/yr for RYOIX. Their correlation of 0.83 suggests significant overlap in exposure. SHSAX charges 1.09%/yr vs 1.36%/yr for RYOIX.
Performance
SHSAX vs. RYOIX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, SHSAX achieves a -1.61% return, which is significantly lower than RYOIX's 11.45% return. Both investments have delivered pretty close results over the past 10 years, with SHSAX having a 10.05% annualized return and RYOIX not far ahead at 10.54%.
SHSAX
- 1D
- 1.37%
- 1M
- 1.76%
- YTD
- -1.61%
- 6M
- -2.20%
- 1Y
- 17.76%
- 3Y*
- 6.60%
- 5Y*
- 3.86%
- 10Y*
- 10.05%
RYOIX
- 1D
- 2.06%
- 1M
- 5.30%
- YTD
- 11.45%
- 6M
- 9.38%
- 1Y
- 49.16%
- 3Y*
- 15.68%
- 5Y*
- 5.29%
- 10Y*
- 10.54%
SHSAX vs. RYOIX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
SHSAX BlackRock Health Sciences Opportunities Portfolio | -1.61% | 15.85% | 3.73% | 3.59% | -5.94% | 11.88% | 19.44% | 25.27% | 7.93% | 24.74% |
RYOIX Rydex Biotechnology Fund | 11.45% | 30.62% | -0.95% | 6.06% | -13.04% | 2.05% | 21.94% | 30.69% | -8.94% | 29.68% |
Correlation
The correlation between SHSAX and RYOIX is 0.82, indicating a strong positive relationship between their price movements. Combining them offers limited diversification - they tend to fall together during downturns.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.82 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.77 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.78 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.81 |
Correlation (All Time) Calculated using the full available price history since Jan 3, 2000 | 0.83 |
The correlation between SHSAX and RYOIX has been stable across timeframes, ranging from 0.77 to 0.83 - a consistent structural relationship.
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
SHSAX vs. RYOIX — Risk / Return Rank
SHSAX
RYOIX
SHSAX vs. RYOIX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for BlackRock Health Sciences Opportunities Portfolio (SHSAX) and Rydex Biotechnology Fund (RYOIX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| SHSAX | RYOIX | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.21 | ||
| Sortino ratioReturn per unit of downside risk | -1.55 | ||
| Omega ratioGain probability vs. loss probability | 1.22 | 1.41 | -0.19 |
| Calmar ratioReturn relative to maximum drawdown | 1.82 | 5.80 | -3.98 |
| Martin ratioReturn relative to average drawdown | 4.39 | 21.13 | -16.75 |
Loading charts...
Drawdowns
SHSAX vs. RYOIX - Drawdown Comparison
The maximum SHSAX drawdown since its inception was -35.49%, smaller than the maximum RYOIX drawdown of -74.43%. Use the drawdown chart below to compare losses from any high point for SHSAX and RYOIX.
Loading charts...
Drawdown Indicators
| SHSAX | RYOIX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -35.49% | -74.43% | +38.94% |
Max Drawdown (1Y)Largest decline over 1 year | -9.87% | -8.43% | -1.44% |
Max Drawdown (3Y)Largest decline over 3 years | -16.08% | -23.47% | +7.39% |
Max Drawdown (5Y)Largest decline over 5 years | -17.99% | -33.66% | +15.67% |
Max Drawdown (10Y)Largest decline over 10 years | -28.36% | -33.66% | +5.30% |
Current DrawdownCurrent decline from peak | -4.44% | 0.00% | -4.44% |
Average DrawdownAverage peak-to-trough decline | -6.17% | -27.59% | +21.42% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.09% | 2.31% | +1.78% |
Volatility
SHSAX vs. RYOIX - Volatility Comparison
The current volatility for BlackRock Health Sciences Opportunities Portfolio (SHSAX) is 5.09%, while Rydex Biotechnology Fund (RYOIX) has a volatility of 6.63%. This indicates that SHSAX experiences smaller price fluctuations and is considered to be less risky than RYOIX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| SHSAX | RYOIX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 5.09% | 6.63% | -1.54% |
Volatility (6M)Calculated over the trailing 6-month period | 10.73% | 15.35% | -4.62% |
Volatility (1Y)Calculated over the trailing 1-year period | 14.22% | 19.83% | -5.61% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 14.44% | 21.25% | -6.81% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 16.57% | 23.23% | -6.66% |
SHSAX vs. RYOIX - Expense Ratio Comparison
SHSAX has a 1.09% expense ratio, which is lower than RYOIX's 1.36% expense ratio.
Dividends
SHSAX vs. RYOIX - Dividend Comparison
SHSAX's dividend yield for the trailing twelve months is around 10.81%, less than RYOIX's 11.28% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
RYOIX Rydex Biotechnology Fund | 11.28% | 12.57% | 14.61% | 0.00% | 1.29% | 19.39% | 7.28% | 8.58% | 14.11% | 5.38% | 0.00% | 1.45% |
SHSAX BlackRock Health Sciences Opportunities Portfolio | 10.81% | 10.63% | 9.18% | 3.84% | 7.44% | 9.20% | 4.34% | 3.89% | 8.56% | 3.53% | 2.43% | 12.58% |
Frequently Asked Questions
SHSAX and RYOIX have a correlation of 0.82, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
RYOIX has higher volatility (6.63%) compared to SHSAX (5.09%). In terms of maximum drawdown, SHSAX dropped -35.49% vs RYOIX's -74.43%.
RYOIX currently has the higher Sharpe Ratio (2.47 vs 1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for SHSAX and RYOIX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer